Christine Lindenboom | Senior Vice President-Investor Relations and Corporate Communication |
Yvonne Greenstreet | Chief Executive Officer |
Tolga Tanguler | Chief Commercial Officer |
Pushkal Garg | Chief Medical Officer and EVP, Development & Medical Affairs |
Jeff Poulton | Chief Financial Officer |
Michael Ulz | Morgan Stanley |
David Lebowitz | Citi |
Paul Matteis | Stifel |
Ritu Baral | TD Cowen |
Maury Raycroft | Jefferies |
Eliana Merle | UBS |
William Pickering | Bernstein |
Gena Wang | Barclays |
Leland Gershell | Oppenheimer |
Good day and thank you for standing by. Welcome to the Alnylam Pharmaceuticals Q2 2023 Earnings Conference Call. At this time, participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.